Clinical trial
Gemcitabine Plus Carboplatin Versus Carboplatin Monotherapy in Patients With…
NCT00102414 · AGO Study Group, Other · Completed
Key facts
| NCT number | NCT00102414 |
|---|---|
| Title | Gemcitabine Plus Carboplatin Versus Carboplatin Monotherapy in Patients With Advanced Ovarian Cancer |
| Official title | A Randomized Phase III Study Comparing Gemcitabine Plus Carboplatin Versus Carboplatin Monotherapy in Patients With Advanced Epithelial Ovarian Carcinoma Who Failed First-Line Platinum-Based Therapy |
| Lead sponsor | AGO Study Group, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Ovarian Cancer |
| Intervention type | Drug |
| Interventions | Gemcitabine |
| Enrollment | 356 |
| Start date | Sep 1, 1999 |
| Completion | Nov 1, 2004 |
| First posted | Jan 31, 2005 |
| Last update posted | Nov 14, 2006 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: